Evogene Ltd. (EVGN) vs Nexalin Technology, Inc. (NXL)
A side-by-side comparison of Evogene Ltd. and Nexalin Technology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EVGN
Evogene Ltd.
$0.43HealthcareDelayed quote: Oct 6, 2026, 1:57 PM EDT
NXL
Nexalin Technology, Inc.
$4.79HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
Total return — EVGN vs NXL
growth of $100 · dividends reinvested · last 4yEVGN -96.1% (-55.5%/yr)NXL -92.0% (-46.7%/yr)NXL compounded faster over this window
EVGN NXL
EVGN vs NXL: by the numbers
- •EVGN is the larger company ($4M vs $4M market cap).
- •Both run net losses; EVGN's is the smaller (-694.19% vs -4139.38% net margin).
- •NXL grew revenue faster over the past five years (10.22% vs 2.86% CAGR).
Metrics side by side
Valuation
| Metric | EVGN | NXL |
|---|---|---|
| P/S ratio | 2.82 | 16.18 |
| P/B ratio | N/A | 2.31 |
Profitability
| Metric | EVGN | NXL |
|---|---|---|
| Gross margin | -6.25% | 79.65% |
| Operating margin | -364.24% | -2781.69% |
| Net margin | -694.19% | -4139.38% |
| ROE | N/A | -591.60% |
| ROIC | -130.12% | -600.62% |
Growth (annualized)
| Metric | EVGN | NXL |
|---|---|---|
| Revenue CAGR (5Y) | 2.86% | 10.22% |
| Total return CAGR (5Y) | -56.46% | N/A |
Frequently asked
- Which has grown faster, EVGN or NXL?
- Over the past five years, NXL grew revenue faster — EVGN at a 2.86% CAGR versus NXL at 10.22%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.